Ratings by Loop Capital (Jason Wittes)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/10/2023 | Globus Medical | GMED | Downgrade | Hold (Buy) |
62.97 (77.97) |
23.82% | Details | |
| 2/1/2023 | Stryker | SYK | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Globus Medical | GMED | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Stereotaxis | STXS | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | Brainsway | BWAY | New Coverage | Buy (N/A) |
7.85 (15.43) |
96.56% | Details | |
| 1/5/2022 | Stereotaxis | STXS | New Coverage | Buy (N/A) |
6.44 (1.68) |
-73.91% | Details | |
| 12/22/2021 | Accuray | ARAY | New Coverage | Buy (N/A) |
4.72 (0.26) |
-94.49% | Details | |
| 12/7/2021 | Stryker | SYK | New Coverage | Buy (N/A) |
246.87 (315.75) |
27.9% | Details | |
| 12/7/2021 | Zimmer Biomet | ZBH | New Coverage | Buy (N/A) |
121.22 (124.14) |
2.41% | Details | |
| 10/29/2021 | Alphatec Holdings | ATEC | New Coverage | Buy (N/A) |
11.76 (8.85) |
-24.74% | Details | |
| 10/29/2021 | Globus Medical | GMED | New Coverage | Buy (N/A) |
77.08 (77.97) |
1.15% | Details | |
| 2/8/0008 | NovoCure Ltd. | NVCR | New Coverage | Buy (N/A) |
71.24 (15.28) |
-78.55% | Details |
